























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































SnapShot: Class I PI3K Isoform 
Signaling
Ralph Fritsch1 and Julian Downward1,2
1Signal Transduction Laboratory, Cancer Research UK London Research Institute, 44 Lincoln’s Inn Fields, London WC2A 3LY, UK
2Lung Cancer Group, Division of Cancer Biology, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK
Class I phosphoinositide 3-kinases (PI3Ks) phosphorylate the 3-hydroxyl group of the inositol ring of phosphoinositide (4,5) bisphosphate (PtdIns(4,5)2) to generate the lipid 
second-messenger phosphoinositide (3,4,5) trisphosphate (PtdIns(3,4,5)3), which binds to pleckstrin homology (PH) domains of effector proteins, inducing their plasma mem-
brane translocation and activation. Effectors include serine/threonine and tyrosine protein kinases, adaptor proteins, guanine nucleotide exchange factors (GEFs), and GTPase-
activating proteins (GAPs), altogether orchestrating a large set of cellular signaling pathways that regulate survival, growth, proliferation, motility, and metabolism. PI3K activity 
is tightly controlled, and deregulation leads to a wide range of pathophysiological conditions, including diabetes, inflammation, and cancer.
There exist four class I PI3K isoforms in mammals, named after their respective p110 catalytic subunits. p110α (PIK3CA) and p110β (PIK3CB) are ubiquitously expressed, 
whereas significant expression levels of p110γ (PIK3CG) and p110δ (PIK3CD) are restricted to hematopoietic cells and a few other tissues. Class I isoforms are heterodimers 
composed of a p110 catalytic subunit and a regulatory subunit. p110α, -β, and -δ (class IA) engage p85-type regulatory subunits encoded by PIK3R1 (p85α, p55α, p50α), 
PIK3R2 (p85β), or PIK3R3 (p55γ). All p85 proteins contain two Src homology 2 (SH2) domains and a coiled-coil inter-SH2 (iSH2) domain, which together form the p85 core that 
binds, stabilizes, and inhibits the associated catalytic subunits. The precise mode of interaction between p85 and p110 varies between class IA isoforms, which may lead to 
distinct intrinsic biochemical properties. Upon receptor stimulation, the SH2 domains of p85 bind to phosphotyrosine-containing consensus sequences on receptor tyrosine 
kinases (RTKs) or adaptor proteins. Recruitment of p85 to receptor tyrosine kinases can either be direct through binding of SH2 domains to YXXM motifs on the intracel-
lular domain of the respective RTK (e.g., PDGFR) or can occur indirectly via adaptor proteins (GRB2/GAB for EGFR, IRS1/IRS2 for insulin receptor). This results in membrane 
recruitment of the heterodimer and disinhibition of lipid kinase activity. The single class IB isoform, p110γ, engages p101 or p84 regulatory subunits with incompletely under-
stood structural and functional consequences. Both p110γ/p101 and p110γ/p84 heterodimers are activated by Gβγ subunits from heterotrimeric G proteins, albeit to a different 
extent. Upon G-protein-coupled receptor (GPCR) activation, Gβγ dissociates from Gα and recruits and activates p110γ heterodimers, possibly through binding to both regula-
tory and catalytic subunits. Gβγ also directly binds and activates the ubiquitous class IA p110β isoform through direct interaction with its helical domain, making p110β the only 
PI3K isoform that is directly activated by both tyrosine-phosphorylated proteins and GPCRs. p110β also functions in receptor-mediated endocytosis and autophagy, possibly 
through kinase-independent interaction with RAB5, which stabilizes the latter in its active, GTP-bound confirmation.
Another route to class I PI3K activation is through direct binding of active RAS superfamily GTPases to p110 RAS-binding domains (RBDs). p110α, -γ, and -δ isoforms inter-
act with prototypical RAS proteins and a subset of closely related RAS subfamily GTPases (mainly RRAS proteins), whereas p110β is directly regulated by the RHO subfamily 
GTPases RAC and CDC42. How RAS superfamily GTPases are activated upstream of specific PI3K isoforms and precisely which RAS protein is involved in a given pathway 
may be cell type and context specific. For RAS, both SOS and RASGRP family RAS-GEFs have been implicated through indirect activation by tyrosine-phosphorylated pro-
teins and phospholipase C (PLC)-dependent generation of diacylglycerol (DAG), respectively, whereas RAC was found to be activated downstream of GPCRs and upstream 
of p110β by the bipartite Dock180/Elmo1 RAC-GEF in fibroblasts, possibly through direct binding of Gβγ to Elmo1. The predominant model of class I PI3K isoform activation 
is based on the recruitment of the kinase complex via the regulatory subunit (or through direct Gβγ binding to p110β), coinciding with binding of concomitantly activated RAS 
superfamily GTPases to p110 RBDs. GTPase binding serves to fully recruit, activate, and possibly fine-tune lipid kinase activity, and the in vivo importance of the RBD route 
has been confirmed in mouse models for the α, β, and γ isoforms. It remains, however, unclear whether the transient and low-affinity interaction with RBD interactors alone can 
be sufficient to activate class I PI3K in mammalian cells under normal physiological conditions or whether this always requires coordinated input from tyrosine phosphorylated 
proteins or Gβγ.
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